Cell-based optimization of novel benzamides as potential antimalarial leads
Tao Wu(Genomics Institute of the Novartis Research Foundation), Arnab K. Chatterjee(Scripps Research Institute), Xianming Deng(Xiamen University), Jared Ek(Genomics Institute of the Novartis Research Foundation), Susan Simerson(Genomics Institute of the Novartis Research Foundation), Kerstin Henson(Genomics Institute of the Novartis Research Foundation), Nathanael S. Gray(Stanford University), A. S. Nagle(Genomics Institute of the Novartis Research Foundation), David C. Tully(Genomics Institute of the Novartis Research Foundation), Tove Tuntland(Genomics Institute of the Novartis Research Foundation), Steven Howard(University of Wisconsin–Madison), David Plouffe(Genomics Institute of the Novartis Research Foundation), Zhong Chen(Sun Yat-sen University), Elizabeth A. Winzeler(University of California San Diego), Rachel Borboa(Genomics Institute of the Novartis Research Foundation), Jonathan Chang(Genomics Institute of the Novartis Research Foundation), Tomoyo Sakata(Genomics Institute of the Novartis Research Foundation), John Isbell(Genomics Institute of the Novartis Research Foundation), Francisco Adrián(HiFiBiO Therapeutics (United States)), Kelli Kuhen(Genomics Institute of the Novartis Research Foundation)
Cited by 15
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
|Journal of Biological Chemistry|2009|1.8k